• Twitter
  • Instagram
  • Home
  • Products
    • StarDrop
      • Discover Stardrop
      • Features
      • Modules
      • Integration
      • Case Studies
    • Augmented Chemistry
    • Cerella
    • Ocura
  • Community
    • Optibrium Community
    • Publications & Presentations
    • Downloads
    • Tutorials
    • Videos & Webinars
  • News & Events
    • In the News
    • Events
    • Publications
    • Presentations
    • Newsletter
  • About
    • About Optibrium
    • Our Partners
    • Management Team
    • Careers
  • Contact Us
Optibrium
Try StarDrop™
Try Cerella™
Try Augmented Chemistry®

Guiding Drug Optimisation Using Deep Learning Imputation and Compound Generation

by Thanos Panagiotidis | Sep 10, 2020 | General, Publications and presentations

Guiding Drug Optimisation Using Deep Learning Imputation and Compound Generation International Pharmaceutical Industry : Summer 2020 Vol 12:2 Introduction The use of machine learning (ML) methods is now commonplace in many disciplines and artificial intelligence (AI)...
Multi-parameter Optimisation in Practice

Multi-parameter Optimisation in Practice

by Thanos Panagiotidis | Sep 9, 2020 | Presentations and Webinars, Videos

Multi-parameter Optimisation in Practice Held on 8 September 2020. Multi-parameter Optimisation in Practice This webinar was presented by Ed Champness, Tim Hohm and John Norman. In this webinar you can hear how you can quickly find high-quality compounds for your...

Peer-reviewed Study by Optibrium Demonstrates the Value of Deep Learning for Imputation of Drug Discovery Data

by Thanos Panagiotidis | Sep 9, 2020 | News

Collaboration with Constellation Pharmaceuticals highlights the value of deep learning imputation to exploit heterogeneous drug discovery data. CAMBRIDGE, UK: 9 September 2020 – Optibrium™, leading providers of software and services for drug discovery, today announced...

Recent Posts

  • Matched Pairs Neighbourhood Analysis
  • Ligand-based drug design using Surflex eSim 3D
  • Reaction-based Library Enumeration
  • AI in early Drug Discovery: From Promise to Practice
  • Fast Follower: Optimising P450 Metabolic Stability

Recent Comments

    Archives

    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021
    • August 2021
    • June 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • July 2019
    • June 2019
    • May 2019
    • March 2019
    • February 2019
    • January 2019
    • November 2018
    • October 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018
    • December 2017
    • October 2017
    • June 2017
    • May 2017
    • January 2017
    • December 2016
    • November 2016
    • October 2016
    • September 2016
    • August 2016
    • June 2016
    • May 2016
    • April 2016
    • March 2016
    • February 2016
    • December 2015
    • November 2015
    • October 2015
    • September 2015
    • August 2015
    • June 2015
    • April 2015
    • March 2015
    • February 2015
    • January 2015
    • December 2014
    • November 2014
    • October 2014
    • August 2014
    • July 2014
    • June 2014
    • April 2014
    • March 2014
    • February 2014
    • January 2014
    • November 2013
    • October 2013
    • July 2013
    • June 2013
    • May 2013
    • April 2013
    • February 2013
    • December 2012
    • November 2012
    • October 2012
    • September 2012
    • March 2012
    • October 2011
    • September 2011
    • July 2011
    • April 2011
    • March 2011
    • October 2010
    • September 2010
    • August 2010
    • July 2010
    • June 2010
    • May 2010
    • April 2010
    • March 2010
    • December 2009
    • October 2009
    • September 2009

    Categories

    • Asteris
    • Cerella
    • Downloads
    • Drug Discovery Applications
    • Events/Webinars
    • Example Code
    • General
    • In Silico Modelling
    • Latest Videos
    • Models
    • Multi-Parameter Optimisation
    • News
    • Ocura
    • Pipeline Pilot Protocols
    • Presentations and Webinars
    • Publications and presentations
    • Scoring Profiles
    • Scripts/Addons
    • StarDrop Hints and Tips
    • StarDrop Modules and Features
    • StarDrop Tutorials
    • Tutorials
    • Videos

    Meta

    • Register
    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    The Optibrium team works at the forefront of decision-analysis and predictive modelling research, developing innovative products that enhance the efficiency and productivity of drug discovery.

    enquiries & support

    General: info@optibrium.com
    StarDrop: stardrop-support@optibrium.com
    Cerella: cerella-support@optibrium.com
    Press: press@optibrium.com
    Vacancies: vacancies@optibrium.com

    • Follow
    • Follow
    further information

    View our Privacy Policy

    Copyright © 2021 Optibrium, Ltd. All Rights Reserved.
    Optibrium™, StarDrop™, Augmented Chemistry®, Cerella™, Asteris™, Ocura™, Glowing Molecule™, WhichP450™, Auto-Modeller™, Nova™, MPO Explorer™ and Card View® are trademarks of Optibrium Ltd. Augmented Chemistry® is registered only in the UK and EU. Card View® is registered only in the United States. Matsy™ is a trademark of NextMove Software Ltd., BIOSTER™ is a trademark of iKem Szolgáltató és Kereskedelmi BT, Derek Nexus™ is a trademark of Lhasa Ltd., Surflex eSim3D is a trademark of BioPharmics LLC, and SeeSAR™ is a trademark of BioSolveIT GmbH. US Patent Numbers 9,224,098 and 9,367,812

    Website designed and developed by Identity Creative.